The University of Chicago Header Logo

Connection

Daniel Arber to Bone Marrow

Back to Details
This is a "connection" page, showing publications Daniel Arber has written about Bone Marrow.
Daniel Arber
Connection Strength
5.375
Bone Marrow
  1. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014 Nov; 89(11):E193-9.
    View in: PubMed
    Score: 0.422
  2. New-onset pancytopenia: a diagnostic approach-reply. Hum Pathol. 2014 Jul; 45(7):1552-3.
    View in: PubMed
    Score: 0.412
  3. Bone marrow evaluation in new-onset pancytopenia. Hum Pathol. 2013 Jun; 44(6):1154-64.
    View in: PubMed
    Score: 0.379
  4. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin. Am J Clin Pathol. 2009 Jan; 131(1):49-57.
    View in: PubMed
    Score: 0.287
  5. Prevalence of bone marrow involvement in systemic anaplastic large cell lymphoma: are immunohistochemical studies necessary? Hum Pathol. 2008 Sep; 39(9):1331-40.
    View in: PubMed
    Score: 0.277
  6. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005 Dec; 29(12):1549-57.
    View in: PubMed
    Score: 0.231
  7. Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach. Am J Clin Pathol. 2023 10 03; 160(4):365-393.
    View in: PubMed
    Score: 0.199
  8. Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. Hum Pathol. 2003 May; 34(5):479-83.
    View in: PubMed
    Score: 0.193
  9. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO Precis Oncol. 2023 01; 7:e2200400.
    View in: PubMed
    Score: 0.189
  10. GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues. Am J Clin Pathol. 2022 08 04; 158(2):228-234.
    View in: PubMed
    Score: 0.184
  11. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer. 2002 Mar 01; 94(5):1522-31.
    View in: PubMed
    Score: 0.178
  12. Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC). Am J Clin Pathol. 2020 11 04; 154(6):731-741.
    View in: PubMed
    Score: 0.163
  13. Aggressive B-cell lymphomas with a primary bone marrow presentation. Histopathology. 2020 Sep; 77(3):369-379.
    View in: PubMed
    Score: 0.159
  14. Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy. Histopathology. 2020 06; 76(7):934-941.
    View in: PubMed
    Score: 0.157
  15. Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study. Int J Lab Hematol. 2020 Aug; 42(4):418-422.
    View in: PubMed
    Score: 0.157
  16. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018 05; 31(5):690-704.
    View in: PubMed
    Score: 0.134
  17. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017 08; 102(8):1352-1360.
    View in: PubMed
    Score: 0.128
  18. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Am J Clin Pathol. 1997 Apr; 107(4):430-7.
    View in: PubMed
    Score: 0.127
  19. Revisiting erythroleukemia. Curr Opin Hematol. 2017 03; 24(2):146-151.
    View in: PubMed
    Score: 0.126
  20. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996 Oct; 106(4):462-8.
    View in: PubMed
    Score: 0.123
  21. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica. 2014 May; 99(5):821-9.
    View in: PubMed
    Score: 0.102
  22. The bone marrow agar section: a morphologic and immunohistochemical evaluation. Mod Pathol. 1993 Sep; 6(5):592-8.
    View in: PubMed
    Score: 0.099
  23. STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia. Leukemia. 2013 Nov; 27(11):2244-7.
    View in: PubMed
    Score: 0.096
  24. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol. 2010 Aug; 85(8):600-6.
    View in: PubMed
    Score: 0.080
  25. Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia? Haematologica. 2010 Apr; 95(4):670-3.
    View in: PubMed
    Score: 0.077
  26. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study. Am J Clin Pathol. 2024 Sep 03; 162(3):233-242.
    View in: PubMed
    Score: 0.053
  27. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group. Leuk Res. 2023 07; 130:107309.
    View in: PubMed
    Score: 0.048
  28. Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leuk Lymphoma. 2023 05; 64(5):972-980.
    View in: PubMed
    Score: 0.048
  29. Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation. Leuk Res. 2023 04; 127:107033.
    View in: PubMed
    Score: 0.048
  30. Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Mod Pathol. 2023 03; 36(3):100016.
    View in: PubMed
    Score: 0.047
  31. The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms. Am J Hematol. 2023 01; 98(1):166-179.
    View in: PubMed
    Score: 0.047
  32. Updates on eosinophilic disorders. Virchows Arch. 2023 Jan; 482(1):85-97.
    View in: PubMed
    Score: 0.046
  33. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms. Virchows Arch. 2022 Oct; 481(4):621-646.
    View in: PubMed
    Score: 0.046
  34. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients. Leukemia. 2002 Apr; 16(4):623-31.
    View in: PubMed
    Score: 0.045
  35. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations. Am J Clin Pathol. 2002 Feb; 117(2):306-13.
    View in: PubMed
    Score: 0.044
  36. Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol. 2022 04; 35(4):470-479.
    View in: PubMed
    Score: 0.044
  37. Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia. Am J Clin Pathol. 2001 Jul; 116(1):25-33.
    View in: PubMed
    Score: 0.043
  38. The use of archival bone marrow specimens in detecting B-cell non-Hodgkin's lymphomas using polymerase chain reaction methods. Leuk Lymphoma. 2000 Jan; 36(3-4):347-52.
    View in: PubMed
    Score: 0.038
  39. Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis. Cancer Genet Cytogenet. 1999 Feb; 109(1):58-65.
    View in: PubMed
    Score: 0.036
  40. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry. Am J Clin Pathol. 2015 Apr; 143(4):527-34.
    View in: PubMed
    Score: 0.028
  41. Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia. Am J Hematol. 2012 Jan; 87(1):45-50.
    View in: PubMed
    Score: 0.022
  42. Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis. Am J Clin Pathol. 2006 Oct; 126(4):545-51.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.